Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17

Calligaris, Matteo, Spanò, Donatella Pia, Puccio, Maria Chiara, Müller, Stephan A., Bonelli, Simone, Lo Pinto, Margot, Zito, Giovanni, Blobel, Carl P., Lichtenthaler, Stefan F., Troeberg, Linda ORCID: https://orcid.org/0000-0003-0939-4651 and Scilabra, Simone Dario (2024) Development of a Proteomic Workflow for the Identification of Heparan Sulphate Proteoglycan-Binding Substrates of ADAM17. Proteomics, 24 (23-24). ISSN 1615-9853

[thumbnail of Proteomics - 2024 - Calligaris - Development of a Proteomic Workflow for the Identification of Heparan Sulphate]
Preview
PDF (Proteomics - 2024 - Calligaris - Development of a Proteomic Workflow for the Identification of Heparan Sulphate) - Published Version
Available under License Creative Commons Attribution.

Download (7MB) | Preview

Abstract

Ectodomain shedding, which is the proteolytic release of transmembrane proteins from the cell surface, is crucial for cell-to-cell communication and other biological processes. The metalloproteinase ADAM17 mediates ectodomain shedding of over 50 transmembrane proteins ranging from cytokines and growth factors, such as TNF and EGFR ligands, to signalling receptors and adhesion molecules. Yet, the ADAM17 sheddome is only partly defined and biological functions of the protease have not been fully characterized. Some ADAM17 substrates (e.g., HB-EGF) are known to bind to heparan sulphate proteoglycans (HSPG), and we hypothesised that such substrates would be under-represented in traditional secretome analyses, due to their binding to cell surface or pericellular HSPGs. Thus, to identify novel HSPG-binding ADAM17 substrates, we developed a proteomic workflow that involves addition of heparin to solubilize HSPG-binding proteins from the cell layer, thereby allowing their mass spectrometry detection by heparin-treated secretome (HEP-SEC) analysis. Applying this methodology to murine embryonic fibroblasts stimulated with an ADAM17 activator enabled us to identify 47 transmembrane proteins that were shed in response to ADAM17 activation. This included known HSPG-binding ADAM17 substrates (i.e., HB-EGF, CX3CL1) and 14 novel HSPG-binding putative ADAM17 substrates. Two of these, MHC-I and IL1RL1, were validated as ADAM17 substrates by immunoblotting.

Item Type: Article
Additional Information: Publisher Copyright: © 2024 The Author(s). PROTEOMICS published by Wiley-VCH GmbH.
Uncontrolled Keywords: adam17,ectodomain shedding,heparan sulphate proteoglycans,metalloproteinases,proteomics,secretome analysis,biochemistry,molecular biology ,/dk/atira/pure/subjectarea/asjc/1300/1303
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups: Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 10 Aug 2026 10:14
Last Modified: 10 Aug 2026 10:14
URI: https://ueaeprints.uea.ac.uk/id/eprint/104065
DOI: 10.1002/pmic.202400076

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item